MemorialCare Neuroscience Institute is advancing preventive brain aneurysm care across Southern California by detecting its first successful aneurysm before it ruptured using Rapid Aneurysm technology. Rapid Aneurysm is an artificial intelligence-powered technology, developed by RapidAI, that is embedded in all of MemorialCare’s inpatient and outpatient qualifying brain CT angiography (CTA) and magnetic resonance angiography (MRA) scans to automatically scan for potential aneurysms. It flags these suspected aneurysms for review by radiologists and neuro stroke teams and provides detailed three-dimensional measurements to help physicians determine the plan of care.

"One of the most important challenges in aneurysm care is determining which aneurysms require treatment and which can be monitored safely over time," said Viktor Szeder, M.D., neurointerventionalist, Division of Interventional Neuroradiology, MemorialCare Neuroscience Institute. "Finding an aneurysm before it ruptures gives us time to lower a patient's risk, watch for changes and, if needed, treat it in a planned procedure rather than an emergency. Rapid Aneurysm's precise measurements help us see subtle changes, so we know when monitoring is no longer enough."

According to the Brain Aneurysm Foundation, an estimated 6.8 million Americans are living with an unruptured brain aneurysm, many without symptoms. Because aneurysms can remain undetected until they rupture, early detection and ongoing monitoring are critical to reducing risk and determining when treatment may be necessary. Some aneurysms may be discovered unexpectedly when brain imaging is performed for another medical reason.

“Rapid Aneurysm analyzes CTA and MRA brain scans to automatically flag suspected aneurysms,” said Dr. Szeder. “Traditionally, physicians measure an aneurysm by hand on flat, two-dimensional images, recording its height and width. Because many aneurysms are small and irregularly shaped, slight growth can be difficult to measure consistently from one scan to the next.”

Rapid Aneurysm converts those images into detailed three-dimensional models that measure the aneurysm's full volume and surface area, then compares them across scans to show whether it is growing or changing shape. Growth is one of the key factors physicians weigh when deciding between continued monitoring and treatment, as aneurysms that grow are significantly more likely to rupture than those that remain stable.

Patients do not need a separate scan or appointment for the AI analysis; it is automatically created in the workflow for any MemorialCare patient who receives a CTA or MRA. Radiologists confirm every diagnosis, and patients with a confirmed aneurysm are connected with MemorialCare Neuroscience Institute specialists for follow-up care.

"At MemorialCare, we believe better health starts with prevention and finding risks early," said Liz Acord, vice president of clinical institutes, MemorialCare. "Rapid Aneurysm gives us the opportunity to be proactive rather than reactive. Bringing this technology to all MemorialCare’s patients from the South Bay to South Orange County strengthens our commitment to the health of the communities we serve."

MemorialCare Neuroscience Institute provides neurovascular care at Long Beach Medical Center, Orange Coast Medical Center and Saddleback Medical Center. Long Beach Medical Center is home to a Comprehensive Stroke Center and the Division of Interventional Neuroradiology, which has provided minimally invasive treatment for brain aneurysms, vascular malformations and stroke for 15 years. Its interventional neuroradiologists and stroke neurologists are available 24 hours a day for consultation and emergency treatment.

Learn more about Rapid Aneurysm at memorialcare.org/RapidAI.